We only have this paper's title and publication details.
Read it at the sourceCombination of navitoclax and survivin inhibitor with carboplatin effectively reduces tumor growth in ovarian cancer, indicating a potential new treatment approach.
Primary human ovarian cancer cell characetization
No takes yet. Share an insight, caveat, or question.
Kenny et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: